New Methodology Could Help To Better Treat Mood Disorders
the Psychiatry Advisor take:
A team of scientists is looking to harness the power of “big data” to develop a new methodology and visualization tools to cluster patients with mood disorders. Their aim is to group patients based on comprehensive data profiles, which include genetic, environmental, demographic and clinical data, rather than DSM criteria, which could improve treatment decisions.
Led by Rachael Hageman Blair, PhD, of the University of Buffalo School of Public Health and Health Professions, in New York, the research team includes biostatisticians, information scientists, mathematicians and psychiatrists. They note that studies from the National Institute for Mental Health indicate that treatments for mood disorders are less than 25% effective.
“Our aim is to ignore the DSM label and regroup patients based on comprehensive data profiles, which include genetic, environmental, demographic and clinical data, among others,” Blair said in a statement. “Some groups of individuals may be more responsive to treatment, which is important for precision medicine.”
The next step for the team is to develop the methodology.
The aim is to group patients based on comprehensive data profiles, rather than DSM criteria, which could improve treatment decisions.
Mood disorders like depression are common among U.S. adults. Still, such disorders remain challenging for clinicians to diagnose and treat effectively.
A public health researcher at the University at Buffalo is part of a team of scientists that received a National Science Foundation (NSF) grant to use big data to develop a new approach they say will improve the classification of mood disorders, leading to more effective outcomes for psychiatric patients.
Their aim is to use big data to develop a novel methodology and visualization tools to cluster patients with mood disorders.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk
- FDA to Review Lumateperone for Treatment of Schizophrenia
- AMA Survey Collects Advice for Physicians Approaching Retirement
- Revised Children's Anxiety and Depression Scales Reliable Measurement Tool for Adults
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Cognition, Depression, and Limited Functioning Linked in Middle Age
- Coping With Challenges When Working the Holidays
- Lithium Preferred Method of Maintenance Monotherapy in Older Adults With Bipolar Disorder
- Hypobetalipoproteinemia Associated With Aggression and Schizophrenia
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information